Our vision is to become one of the largest and most profitable non-government owned pharmaceutical companies in China.
Our strategy is to grow aggressively through mergers, joint-ventures and acquisitions targeting state-owned-enterprise pharmaceutical companies and private pharmaceutical companies with outstanding potential.
